Articles On Althea Group Holdings (ASX:AGH)

Where are we in terms of US legalisation of cannabis? What about the current legal landscape for cannabis in Australia? We look at the best performing ASX weed stocks this past month   Global weed stocks have been on bumpy ride over the p...

Australian-founded medicinal cannabis company Althea Group (ASX: AGH) has announced staff redundancies that have shaved $1.5 million from its cost base as the first phase of a planned restructure in the wake of a challenging time for the se...

Medicines cannabis company Althea Group Holdings (ASX:AGH) has updated on developments in France’s generalisation of the use of related products.

Material uncertainties have been raised about two of the largest medicinal cannabis companies listed on the ASX to continue as going concerns, after Cann Group (ASX: CAN) and Althea Group (ASX: AGH) incurred December half losses of $14.3 mi...

Cannabis stocks could rise after the removal of US House Speaker Montu says TGA has to allow the term ‘medicinal cannabis’ to be used We look at the best performing ASX weed stocks over the past month   Some experts believe cannabis stock...

Althea’s cannabis oil approved for reimbursement in Ireland Imugene dosed first patient in onCARlytics Phase 1 trial on solid tumours   Althea’s cannabis oil approved for reimbursement Cannabis company Althea Group (ASX:AGH) has announced...

News relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD fell heavily last week But Goldman analysts say they won’t change ratings on these 3 stocks   Goldman Sachs analysts said they will make no...

Global Health announces deal with Fujitsu Australia Althea raises $5.32m in sale and leaseback deal Immutep to present data from TACTI-002 in key international forum   Global Health signs with Fujitsu Global Health (ASX:GLH), a provider o...

Stockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might have slipped beneath your radar. Below is a wrap of the top 20 performing stocks, by percentage, who made announcements today.   ICYMI Leader...

Stockhead’s Top 10 at shortly-before-11-ish, produced as on-time as humanly possible, despite being handicapped by some decidedly non-human and highly-unfriendly technology. On a slightly-related note, if anyone out there needs parts for an...

Althea extends contract in Canada Clarity moves forward to cohort 3 Cynata opens Phase 2 recruitment   Althea extends deal in Canada for cannabis drinks Cannabis company Althea Group (ASX:AGH) announced that its wholly owned subsidiary, P...

ASX cannabis share Althea Group Holdings Ltd (ASX: AGH) leapt by as much as 27% this morning after the company revealed record quarterly sales of $9.24 million. The company also achieved its maiden monthly operating profit in March, and...

Althea Group (AGH) secures an additional $2.2 million in funding through convertible notes The funding boost comes from US-based institutional investor, Obsidian Global Partners The money will support the launch of AGH’s new SKU’s, an...

Two more US states join the 19 that already allow legal recreational cannabis use ECS Botanics’ Victorian medical cannabis facility is safe from flooding in the state, so far Cann looks to commercialise its Satipharm CBD capsules for over-...

Cannabis-based medicine supplier Althea Group (AGH) receives firm commitments to raise $1.5 million via a share placementThe money will be raised through the issue of 22.4 million new fully-paid ordinary shares to institutional and sophisti...

Althea Group (AGH) enters a trading halt while it plans an upcoming capital raiseIn its September quarterly report, the medicinal cannabis company says the capital raise will “improve its financial position” after a period of increased oper...

It’s time to get cozy and laugh at the lunacy that’s been unfolding here – and abroad – at the intersections of business, entertainment and news, and perilously close to the boundaries of good taste. So let’s kick off our sensible polyester...

ASX 200 rises over 1% on Monday after strong US leads, before Tuesday RBA meeting Small cap index finds nuthin’ as energy, materials fall Up circa 550%, WA1 is still rising   This is happening. Always trust a chartered professional accoun...

Cambridge says cannabis smokers are not actually lazy, that’s a myth USyd wants to test home-grown cannabis in the ACT Incannex joins the big leagues S&P/ASX300 index   It turns out that the lazy stoner stereotype is actually a myth,...

Invion’s lead drug is found to be effective against anal cancer Althea launches new cannabis products Invion (ASX:IVX) surged 17% this morning after telling the market that its lead drug INV043 is effective against anal cancer. A vitro st...

Cannabis-based medicine supplier Althea (AGH) launches two new products to meet patient needsAlthea CBD25 is the company’s exclusive range of soft gel capsules which contain less than 25mg of cannabidiol and less than 0.25mg of THCSubject t...

Cannabis-based medicine supplier Althea Group (AGH) records growth across most key metrics in its two arms of business for the 2022 financial yearThe company grew its revenue by 77.8 per cent to $20.52 million and improved its cash outflows...

Benchmark sags as Materials sector delivers even more tedious disappointment Coal miners hand back yesterday’s gains as investors tire of Chinese whispers Cannabis offers relief for investors and health stocks climb as well. The ASX has e...

ECS is selling its medicinal cannabis farm in Tasmania Crypto ATMs are now a thing in weed dispensaries in the US Zelira Therapeutics nabs regulatory approval in Germany for insomnia medication Ever fancied your own cannabis farm? Well, t...

The Althea Group Holdings Ltd (ASX: AGH) share price is up 5.25% today and up 21.25% over the past four days, as the nano-cap grabs the attention of ASX investors again. Althea is an ASX cannabis share. The company is focused on the manuf...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to start the week with a sizeable decline. At the time of writing, the benchmark index is down 0.95% to 6,614.3 points. Four shares that are not letting that hold them b...

Cannabis company Althea Group (AGH) achieves a record quarter with $6.5 million in receipts for customers, a 130 per cent increase from the previous corresponding period This means that over FY22, AGH tabled $22 million in receipts from cu...

Over the past decade, opioid-induced deaths were more likely to be due to prescription drugs than illegal drugs As scientists discover new ways to use the plant’s medicinal compounds, cannabis is seen as a possible solution to the opioid c...

The Health Products Regulatory Authority approves Althea’s (AGH) CBD12:THC10 product to be used as prescription and supply in Ireland The approval marks Althea’s entry into the Irish medicinal cannabis market, and the first stop of its pla...

The Market Herald brings together several cannabis industry insiders to discuss the market Industry experts discuss the changing nature of the regulatory framework in various jurisdictions, and the growing science-based sophistication of c...

Althea Group (AGH) sees its best first-half result to date with $9.4 million in revenue reported, an 84 per cent increase compared to this time last year The medicinal cannabis company saw cash receipts total $9.9 million, a 67 per cent in...

At the time of writing, the ASX 200 Health Index (XHJ) is down by 1.10%, while the benchmark ASX 200 has fallen by 2.15%. It’s all about earnings today for ASX health stocks. Here’s a highlight of where they stand in the first half.   Round...

Althea Group’s (AGH) German sales and distribution partner Nimbus Health is set to be acquired by global pharmaceutical company Dr Reddy’s Laboratories The NYSE-listed company says it will build on Nimbus Health’s strengths and introduce m...

Medical imaging software Resonance Health (ASX:RHT) has received the green light in the US for its LiverSmart medical device, making it eligible for recognition by the US government agencies and private insurers. Resonance received confirma...

Key points Althea delivered a record performance during the second quarter Strong demand for pharmaceutical cannabis helped drive its growth Althea is still burning through its cash despite its sales growth The Althea Group Holdings Ltd...

ASX cannabis shares were nothing short of a mixed bag last month. Several names did well but a large body of shares missed the benchmark completely. For some context, the S&P/ASX 200 Health Care index (ASX: XHJ) regained steam over th...

ASX cannabis shares were once one of the hottest sectors with no shortage of new pot stocks hitting the market. The Cann Group Ltd (ASX: CAN) share price, for example, skyrocketed almost 300% between September 2017 and January 2018 amid t...

Althea Group (AGH) hit a new high of $4.5 million in customer receipts over the recently completed September quarter The cannabis products producer explains receipts increased 116 per cent year on year and 57 per cent when compared to the...

Wall Street extends rebound US stocks mainly rose on Monday, in a continuation of the upward momentum at the end of last week. The S&P 500 index rose by 0.34% while the Nasdaq was up 0.84%, but the Dow Jones fell slightly (by 0.1%). Dat...

Last week California Governor Gavin Newsom signed Assembly Bill (AB-45), formally permitting the sales of hemp-derived CBD products in the state. Hemp has been legalised at the US federal level since 2018, but state agencies have been slow...

The growth of the global cannabis market and its associated products has been nothing short of phenomenal over the past five years, and Althea Group Holdings (AGH) says cannabis-infused drinks are next on the menu Landmark legislative chan...

The Little Green Pharma Ltd (ASX: LGP) share price has had a tough run over the past few months. This comes despite the medicinal cannabis producer releasing some positive announcements to the market of late. At Friday’s closing bell, Litt...

The Boston Beer Company (NYSE:SAM) is set to launch a new range of non-alcoholic cannabis-infused drinks in Canada with the help of Australian listed Althea Group Holdings’ (ASX:AGH) subsidiary. Peak processing Solutions will research and d...

Highlights EBOS (ASX:EBO) acquires Sentry Medical to expand into medical consumables Piedmont (ASX:PLL) completes initial investment in IronRidge Knosys (ASX:KNO) completes acquisition of LIBERO The S&P/ASX200 closed lower We...

Local stocks struggled for traction in Wednesday trade, as the major indexes drifted sideways following a weak lead out of the US. Banks and energy stocks were up, offsetting falls in resources and consumer staples. There were few major cat...

Highlights Biotechnology firm Mesoblast extended its loss on disappointing earnings and dropped 5%. Graphite producer Volt Resources dropped despite successfully raising capital via share placement. Medical data and technology firm He...

Highlights The ASX 200 declined as much as 1% by lunchtime as investors awaited June quarter GDP figures. Australia’s Q2 GDP rose 0.7% in the June quarter. Barring energy, all indices were trading in the red, while healthcare declined...

The Althea Group Holdings Ltd (ASX: AGH) share price is soaring today following news the company will soon be producing cannabis-infused drinks. A subsidiary of Althea has entered into agreements with Boston Beer Company Inc (NYSE: SAM) to...

Historic American brewery The Boston Beer Company (BCC) has tapped an Australian cannabis manufacturer to launch a new range of non-alcoholic cannabis-infused beverages in Canada. Under the deal, a subsidiary of Melbourne-based Althea Grou...

The Althea Group Holdings Ltd (ASX: AGH) share price has returned to trading today only to get smoked by investors. The cannabis company provided an update to market on its latest capital raising efforts. At the time of writing, Althea sha...